Scynexis (SCYX) Return on Sales Growth (3y) (2016 - 2026)
Scynexis (SCYX) Return on Sales Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00 |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 29.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.00 |
| Dec 31, 2025 | 13.00 |
| Sep 30, 2025 | -7.00 |
| Jun 30, 2025 | 5.00 |
| Mar 31, 2025 | -13.00 |
| Dec 31, 2024 | 44.00 |
| Sep 30, 2024 | -3.00 |
| Jun 30, 2024 | -17.00 |
| Mar 31, 2024 | 1.00 |
| Mar 31, 2023 | 617.00 |
| Dec 31, 2022 | 335.00 |
| Sep 30, 2022 | 184.00 |
| Jun 30, 2022 | 137.00 |
| Mar 31, 2022 | 183.00 |
| Dec 31, 2021 | 91.00 |
| Sep 30, 2021 | 170.00 |
| Jun 30, 2021 | 98.00 |
| Mar 31, 2021 | 94.00 |
| Mar 31, 2020 | -549.00 |
| Jun 30, 2019 | -144.00 |